McCrimmon, RJ, Ryan, CM, Frier, BM. Diabetes and cognitive dysfunction. Lancet. 2012;379:2291-2299.
Munshi, M, Grande, L, Hayes, M, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care. 2006;29:1794-1799.
Biessels, GJ, Deary, IJ, Ryan, CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008;7:184-190.
Biessels, GJ, Staekenborg, S, Brunner, E, Brayne, C, Scheltens, P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64-74.
Ryan, JP, Fine, DF, Rosano, C. Type 2 diabetes and cognitive impairment: contributions from neuroimaging. J Geriatr Psychiatry Neurol. 2014;27:47-55.
Bozzali, M, Cherubini, A. Diffusion tensor MRI to investigate dementias: a brief review. Magn Reson Imaging. 2007;25:969-977.
Hsu, JL, Chen, YL, Leu, JG, et al. Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage. 2012;59:1098-1105.
Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
Southern, L, Williams, J, Esiri, MM. Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia. BMC Neurol. 2007;7:35.
Horie, K, Miyata, T, Yasuda, T, et al. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer’s disease and aged neurons. Biochem Biophys Res Commun. 1997;236:327-332.
Ikeda, K, Higashi, T, Sano, H, et al. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry. 1996;35:8075-8083.
Bar, KJ, Franke, S, Wenda, B, et al. Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer’s disease and vascular dementia. Neurobiol Aging. 2003;24:333-338.
Nasreddine, ZS, Phillips, NA, Bedirian, V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699.
Folstein, MF, Folstein, SE, McHugh, PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
Morris, JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
Hu, S, He, W, Liu, Z, Xu, H, Ma, G. The accumulation of the glycoxidation product N(epsilon)-carboxymethyllysine in cardiac tissues with age, diabetes mellitus and coronary heart disease. Tohoku J Exp Med. 2013;230:25-32.
Jenkinson, M, Bannister, P, Brady, M, Smith, S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17:825-841.
Smith, SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17:143-155.
van Deutekom, AW, Niessen, HW, Schalkwijk, CG, Heine, RJ, Simsek, S. Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus. Eur J Endocrinol. 2008;158:655-660.
Genuth, S, Sun, W, Cleary, P, et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes. 2005;54:3103-3111.
McCance, DR, Dyer, DG, Dunn, JA, et al. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest. 1993;91:2470-2478.
Smith, SM, Jenkinson, M, Johansen-Berg, H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31:1487-1505.
Last, D, Alsop, DC, Abduljalil, AM, et al. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care. 2007;30:1193-1199.
van Harten, B, de Leeuw, FE, Weinstein, HC, Scheltens, P, Biessels, GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care. 2006;29:2539-2548.
Brownlee, M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med. 1995;46:223-234.
Furth, AJ. Glycated proteins in diabetes. Br J Biomed Sci. 1997;54:192-200.
Yaffe, K, Lindquist, K, Schwartz, AV, et al. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology. 2011;77:1351-1356.
Takeuchi, M, Yamagishi, S. TAGE (toxic AGEs) hypothesis in various chronic diseases. Med Hypotheses. 2004;63:449-452.
Reijmer, YD, Brundel, M, de Bresser, J, et al. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care. 2013;36:137-144.
Kodl, CT, Franc, DT, Rao, JP, et al. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes. 2008;57:3083-3089.
Yau, PL, Javier, D, Tsui, W, et al. Emotional and neutral declarative memory impairments and associated white matter microstructural abnormalities in adults with type 2 diabetes. Psychiatry Res. 2009;174:223-230.
Falvey, CM, Rosano, C, Simonsick, EM, et al. Macro- and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care. 2013;36:677-682.
Gold, SM, Dziobek, I, Sweat, V, et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia. 2007;50:711-719.
Chen, HT, Lin, HD, Won, JG, et al. Cardiovascular autonomic neuropathy, autonomic symptoms and diabetic complications in 674 type 2 diabetes. Diabetes Res Clin Pract. 2008;82:282-290.
Hsu, WC, Chiu, YH, Chen, WH, Chiu, HC, Liou, HH, Chen, TH. Simplified electrodiagnostic criteria of diabetic polyneuropathy in field study (KCIS No. 14). Neuroepidemiology. 2007;28:50-55.